Genentech Inc:企業の戦略的SWOT分析

◆英語タイトル:Genentech Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C15787
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Genentech Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology, metabolism, primary care, neurology, virology, hematology and specialty care. Its pipeline products include Emicizumab (RG6013, ACE910), a bispecific monoclonal antibody used to replace the function of protein in the blood clotting process; and other products. The company has partnership with BioLineRx, Charles River Laboratories International and Amunix, among others. Genentech is headquartered in South San Francisco, California, the US.

Genentech Inc Key Recent Developments

Mar 11,2019 Susan G. Komen Announces New Funding Opportunity Focused on Better Understanding of Breast Cancer Disparities
Feb 11,2019 Samsung Bioepis forms new alliance to expand in China
Feb 06,2019 Xencor and Genentech partner on novel IL-15 cytokine drugs
Jan 24,2019 Genentech announces Alexander Hardy as Chief Executive Officer
Jan 17,2019 PhRMA welcomes Genentech and Gilead Sciences to association

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Genentech Inc – Key Facts
Genentech Inc – Key Employees
Genentech Inc – Key Employee Biographies
Genentech Inc – Major Products and Services
Genentech Inc – History
Genentech Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Genentech Inc – Business Description
Genentech Inc – SWOT Analysis
SWOT Analysis – Overview
Genentech Inc – Strengths
Genentech Inc – Weaknesses
Genentech Inc – Opportunities
Genentech Inc – Threats
Genentech Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Genentech Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 11, 2019: Susan G. Komen Announces New Funding Opportunity Focused on Better Understanding of Breast Cancer Disparities
Feb 11, 2019: Samsung Bioepis forms new alliance to expand in China
Feb 06, 2019: Xencor and Genentech partner on novel IL-15 cytokine drugs
Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer
Jan 17, 2019: PhRMA welcomes Genentech and Gilead Sciences to association
Jan 09, 2019: NIIMBL Announces New Projects to Advance Biopharmaceutical Manufacturing
Nov 28, 2018: Roche subsidiary Genentech to acquire Jecure Therapeutics
Oct 04, 2018: Positive Phase III Results for Baloxavir Marboxil in People at High Risk of Complications From Influenza to be Presented at IDWeek 2018
Sep 13, 2018: FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis[Newswire : Healthcare-BW]
Jul 19, 2018: Genentech to present new data demonstrating the breadth and depth of its alzheimer’s program at the upcoming Alzheimer’s Association International Conference (AAIC)
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Genentech Inc, Key Facts
Genentech Inc, Key Employees
Genentech Inc, Key Employee Biographies
Genentech Inc, Major Products and Services
Genentech Inc, History
Genentech Inc, Other Locations
Genentech Inc, Key Competitors
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Genentech Inc, Recent Deals Summary

List of Figures
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Genentech Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KCOM Group PLC (KCOM):企業の財務・戦略的SWOT分析
    Summary KCOM Group PLC (KCOM) is a technology company that provides communication and information technology services. The company provides IT and integration services, including cloud-based infrastructure and contact and collaboration solutions. It offers broadband and telephony services for consum …
  • Illumina, Inc. (ILMN):企業の財務及び戦略的SWOT分析
    Illumina, Inc. (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CGN New Energy Holdings Co Ltd (1811):企業の財務・戦略的SWOT分析
    CGN New Energy Holdings Co Ltd (1811) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Berwind Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Berwind Corporation Mergers and …
  • Swisher Hygiene, Inc.:企業のM&A・提携・投資分析
    Swisher Hygiene, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swisher Hygiene, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Ihara Chemical Industry Co., Ltd. (4989):企業の財務及び戦略的SWOT分析
    Summary Ihara Chemical Industry Co., Ltd. (ICI) is a chemical company that conducts research and develops, manufactures and sells fine chemicals. The company offers gricultural chemicals, fine chemicals and curing agents. ICI’s agricultural chemicals include herbicide, fungicide, acaricide and PGR. …
  • BioMarin Pharmaceutical Inc (BMRN):企業のM&A・提携動向(医療機器分野)
    Summary BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals that treat serious diseases and medical conditions. The company offers products for the treatment of various diseases such as Kyndrisa (drisapersen), Duchenne mu …
  • Mitsubishi Heavy Industries Ltd (7011)-エネルギー分野:企業M&A・提携分析
    Summary Mitsubishi Heavy Industries Ltd (MHI) is a manufacturer of heavy machinery. It offers a diverse range of products and services for power plants, chemical plants, environmental equipment, steel structures, industrial and general machinery, shipbuilding, aircraft, space systems and air-conditi …
  • Kinder Morgan Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Kinder Morgan Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Kinder Morgan Inc (KMI) is a midstream energy infrastructure company that owns and operates through a network of pipelines and terminals. Its pipelines transport natural gas, crude oil, gasoline, conde …
  • Taiwan Hopax Chemicals Mfg. Co., Ltd. (6509):企業財務及び戦略的SWOT分析
    Summary Taiwan Hopax Chemicals Mfg. Co., Ltd. (Hopax) is a chemical company that manufactures and markets paper making chemicals. The company manufactures biological regents, surface treatment, polymer applied chemical, green chemical, technology and materials. It provides dispersants, carbonless pa …
  • Amazon.com, Inc.:企業のM&A・提携・投資分析
    Amazon.com, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amazon.com, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Mitsubishi Logistics Corporation:企業の戦略・SWOT・財務分析
    SummaryMitsubishi Logistics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • AGRANA Beteiligungs-AG:企業の戦略・SWOT・財務分析
    SummaryAGRANA Beteiligungs-AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Molecular Health GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Health GmbH (Molecular Health) is a biomedical company that designs, develops, manufactures and commercializes software systems which performs integrated analysis of clinical and genomic patient data to support treatment decisions and provide related services. The company offers Mo …
  • Isogenica Ltd.(製薬・医療分野):企業M&A動向
    Summary Isogenica Ltd. (Isogenica) is a biotechnology company. The company provides protein engineering to pharmaceutical and biotechnology companies for the discovery, identification and design of new peptide, polypeptide, protein and antibody compounds using their technology. Its services include …
  • ESTsoft Corp. (047560):企業概要、財務及び戦略的SWOT分析
    Summary ESTsoft Corp. (ESTsoft) is an information technology company. The company develops online games and software products. Its software products include AL tools, utility software for compression and file transfer; InternetDISK, which provides online web storage solutions; securedisk, an enterpr …
  • Inception Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Inception Sciences Inc (Inception Sciences) is a pharmaceutical company that offers drug discovery incubators. The company develops new companies in partnership with academic researchers and biopharmaceutical companies. It develops drugs for various indications such as fibrotic diseases, onc …
  • Empresas CMPC S.A.:企業の戦略・SWOT・財務分析
    SummaryEmpresas CMPC S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Marfrig Global Foods SA:企業概要・SWOT・財務分析
    Summary Canadean's "Marfrig Global Foods SA : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business …
  • AutoTrader Group, Inc. (Formerly AutoTrader.com, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AutoTrader Group, Inc. (Formerl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆